CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: Two case reports

被引：15

作者：

Abruzzese, E ^{[1
]}

Cantonetti, M

Morino, L

Orlandi, G

Tendas, A

Del Principe, MI

Masi, M

Amadori, S

Orlandi, A

Anemona, L

Campione, E

机构：

[1] Univ Roma Tor Vergata, Dept Hematol, S Eugenio Hosp, Rome, Italy

[2] Univ Roma Tor Vergata, Dept Pathol, S Eugenio Hosp, Rome, Italy

[3] Univ Roma Tor Vergata, Dept Dermatol, S Eugenio Hosp, Rome, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 22期

关键词：

D O I：

10.1200/JCO.2003.99.170

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4256 / 4258

页数：3

共 15 条

[1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].

Andersen, MK ;

Pedersen-Bjorgaard, J ;

Kjeldsen, L ;

Dufva, IH ;

Brondum-Nielsen, K .

LEUKEMIA, 2002, 16 (07) :1390-1393

[2] Philadelphia (Ph) chromosome-positive chronic myeloid leukaemia relapsing as Ph-negative leukaemia after allogeneic bone marrow transplantation [J].

Au, WY ;

Lie, AKW ;

Ma, SK ;

Wan, TSK ;

Liang, R ;

Leung, YH ;

Kwong, YL .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) :365-368

[3]

Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139

[4] INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].

DALEY, GQ ;

VANETTEN, RA ;

BALTIMORE, D .

SCIENCE, 1990, 247 (4944) :824-830

[5] The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells [J].

Deininger, MWN ;

Goldman, JM ;

Lydon, N ;

Melo, JV .

BLOOD, 1997, 90 (09) :3691-3698

[6] Trial of IFN or STl571 before proceeding to allografting for CML? [J].

Hehlmann, R .

LEUKEMIA, 2000, 14 (09) :1560-1562

[7] LOCALIZATION OF THE C-ABL ONCOGENE ADJACENT TO A TRANSLOCATION BREAK POINT IN CHRONIC MYELOCYTIC-LEUKEMIA [J].

HEISTERKAMP, N ;

STEPHENSON, JR ;

GROFFEN, J ;

HANSEN, PF ;

DEKLEIN, A ;

BARTRAM, CR ;

GROSVELD, G .

NATURE, 1983, 306 (5940) :239-242

[8] Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature [J].

Ichinohasama, R ;

Miura, I ;

Takahashi, N ;

Sugawara, T ;

Tamate, E ;

Endoh, K ;

Endoh, F ;

Naganuma, H ;

DeCoteau, JF ;

Griffin, JD ;

Kadin, ME ;

Ooya, K .

LEUKEMIA, 2000, 14 (01) :169-182

[9]

Kilic T, 2000, CANCER RES, V60, P5143

[10] The tyrosine kinase inhibitor STI571, like interferon-α, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia [J].

Marley, SB ;

Deininger, MWN ;

Davidson, RJ ;

Goldman, JM ;

Gordon, MY .

EXPERIMENTAL HEMATOLOGY, 2000, 28 (05) :551-557

← 1 2 →